Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $9.35 million. The enterprise value is $2.43 million.

Market Cap	9.35M
Enterprise Value	2.43M

Important Dates

The last earnings date was Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

PCSA has 40.28 million shares outstanding. The number of shares has increased by 284.85% in one year.

Current Share Class	40.28M
Shares Outstanding	40.28M
Shares Change (YoY)	+284.85%
Shares Change (QoQ)	+63.43%
Owned by Insiders (%)	1.14%
Owned by Institutions (%)	1.76%
Float	35.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.53
P/TBV Ratio	1.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.00.

Current Ratio	3.45
Quick Ratio	3.34
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -212.38% and return on invested capital (ROIC) is -131.95%.

Return on Equity (ROE)	-212.38%
Return on Assets (ROA)	-102.62%
Return on Invested Capital (ROIC)	-131.95%
Return on Capital Employed (ROCE)	-212.16%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.04% in the last 52 weeks. The beta is 1.31, so PCSA's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-87.04%
50-Day Moving Average	0.25
200-Day Moving Average	0.57
Relative Strength Index (RSI)	50.22
Average Volume (20 Days)	5,980,224

Short Selling Information

The latest short interest is 2.89 million, so 7.18% of the outstanding shares have been sold short.

Short Interest	2.89M
Short Previous Month	859,990
Short % of Shares Out	7.18%
Short % of Float	8.27%
Short Ratio (days to cover)	0.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.96M
Pretax Income	-9.83M
Net Income	-12.88M
EBITDA	-12.96M
EBIT	-12.96M
Earnings Per Share (EPS)	-$1.64

Balance Sheet

The company has $6.94 million in cash and $25,584 in debt, giving a net cash position of $6.91 million or $0.17 per share.

Cash & Cash Equivalents	6.94M
Total Debt	25,584
Net Cash	6.91M
Net Cash Per Share	$0.17
Equity (Book Value)	6.11M
Book Value Per Share	0.15
Working Capital	5.08M

Cash Flow

In the last 12 months, operating cash flow was -$10.85 million and capital expenditures -$3,244, giving a free cash flow of -$10.85 million.

Operating Cash Flow	-10.85M
Capital Expenditures	-3,244
Free Cash Flow	-10.85M
FCF Per Share	-$0.27

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-284.85%
Shareholder Yield	-284.85%
Earnings Yield	-137.83%
FCF Yield	-116.13%

Analyst Forecast

The average price target for PCSA is $2.00, which is 762.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.00
Price Target Difference	762.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 1:20.

Last Split Date	Jan 22, 2024
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1